See the DrugPatentWatch profile for lipitor

Based on the information available, there is no definitive evidence that Lipitor, a medication commonly used to treat high cholesterol, directly alters protein production in the human body as an adverse reaction [1]. Lipitor, also known as atorvastatin, is a type of statin drug that works by blocking a specific enzyme in the body (HMG-CoA reductase) that is crucial for the production of cholesterol [1].

Adverse reactions associated with Lipitor typically include muscle pain, liver damage, and increased blood sugar levels [1]. While these side effects can have various impacts on the body, they do not directly involve altering protein production [1].

It's important to note that drug manufacturers are required to report all serious and unexpected adverse reactions to the Food and Drug Administration (FDA) [2]. The FDA then evaluates these reports to determine whether any action is needed, such as updating the drug's label or issuing a warning [2]. As of the time of this writing, there are no such updates or warnings related to Lipitor and protein production [1].

In conclusion, based on the available information from DrugPatentWatch.com and other sources, Lipitor does not appear to have adverse reactions that involve altering protein production [1].

Sources:
[1] DrugPatentWatch.com. (n.d.). Atorvastatin. Retrieved from https://www.drugpatentwatch.com/drugs/atorvastatin
[2] U.S. Food and Drug Administration. (n.d.). Drug Safety and Availability - How FDA evaluates reported safety issues to protect public health. Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/how-fda-evaluates-reported-safety-issues-protect-public-health